biomedicina slovenica


angiotensin- : 227

  1. Jevnikar Kristina; Lapajne Luka; Petrovič Danijel; Meglič Andrej; Logar Mateja; Vidović Valentinčič Nataša; Globočnik Petrovič Mojca; Cilenšek Ines; Jaki Mekjavić Polona
    The role of ACE, ACE2, and AGTR2 polymorphisms in COVID-19 severity and the presence of COVID-19-related retinopathy
    2022
  2. Abdin Amr; Bauersachs Johann; Frey Norbert; Kindermann Ingrid; Link Andreas; Marx Nikolaus; Lainščak Mitja; Slawik Jonathan; Wintrich Jan; Böhm Michael
    Timely and individualized heart failure management
    2021
  3. Kopač Peter; Custovic Adnan; Zidarn Mihaela; Šilar Mira; Šelb Julij; Bajrović Nisera; Eržen Renato; Košnik Mitja; Korošec Peter
    Biomarkers of the severity of honeybee sting reactions and the severity and threshold of systemic adverse events during immunotherapy
    2021
  4. Ristić Smiljana; Starčević-Čizmarević Nada; Sepčić Juraj; Kapović Miljenko; Peterlin Borut
    Angiotensin-converting enzyme insertion/deletion gene polymorphism in multiple sclerosis
    2016
  5. Altmaier Elisabeth; Menni Cristina; Heier Margit; Meisinger Christa; Thorand Barbara; Quell Jan; Kobl Michael; Römisch-Margl Werner; Valdes Ana M.; Adamski Jerzy
    The pharmacogenetic footprint of ACE inhibition
    2016
  6. Bajželj Matija; Anderluh Marko
    Sistematični pregled in napoved toksičnosti potencialnih učinkovin za zdravljenje COVID-19
    [Systematic review and toxicity prediction of potential COVID-19 drugs]
    2020
  7. Bousquet Jean; Cristol Jean-Paul; Czarlewski Wienczyslawa; Antò i Boquè Josep M.; Martineau Adrian; Haahtela Tari; Fonseca Susana C.; Iaccarino Guido; Blain Hubert; Fiocchi Alessandro; Bajrović Nisera; Edelbaher Natalija; Jošt Maja; Kopač Peter; Koren Anja; Košnik Mitja; Kramer Vrščaj Karmen; Kreft Samo; Lalek Nika; Madjar Bojan; Poplas-Susič Tonka; Rozman Sinur Irma; Soklič Tanja; Triller Vadnal Katja; Triller Nadja; Urbančič Jure; Zidarn Mihaela
    Nrf2-interacting nutrients and COVID-19
    2020
  8. Rossignol Patrick; Lainščak Mitja; Crespo Leiro Marisa; Laroche Cécile; Piepoli Massimo Francesco; Filippatos Gerasimos; Rosano Giuseppe M.; Savarese Gianluigi; Anker Stefan D.; Seferović Petar M.; Fras Zlatko
    Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes
    2020
  9. Bousquet Jean; Antò i Boquè Josep M.; Laccarino Guido; Czarlewski Wienczyslawa; Haahtela Tari; Anto Aram; Akdis Cezmi A.; Blain Hubert; Canonica Giorgio Walter; Kramer Vrščaj Karmen; Haahtela Tari; Košnik Mitja; Koren Anja; Kopač Peter; Jošt Maja; Kreft Samo; Jenko Klemen; Madjar Bojan; Plavec Davor; Soklič Tanja; Urbančič Jure
    Is diet partly responsible for differences in COVID-19 death rates between and within countries?
    2020
  10. Ruggenenti Piero; Trillini Matias; Pongrac Barlovič Draženka; Cortinovis Monica; Pisani Antonio; Parvanova Aneliya; Iliev Ilian P.; Ruggiero Barbara; Janež Andrej; Gregorič Nadan
    Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes
    2019
  11. Keber Tajda; Tretjak Martin; Cokan Vujkovac Andreja; Mravljak Marija; Ravber Katja; Vujkovac Bojan
    Paricalcitol as an antiproteinuric agent can result in the deterioration of renal and heart function in a patient with Fabry disease
    2017
  12. Pitt Bertram; Bakris George L.; Weir Matthew R.; Freeman Mason W.; Lainščak Mitja; Mayo Martha R.; Garza Dahlia; Zawadzki Rezi; Berman Lance; Bushinsky David A.
    Long-term effects of patiromer for hyperkalaemia treatment in patients with mild heart failure and diabetic nephropathy on angiotensin-converting enzymes/angiotensin receptor blockers
    2018
  13. Zupanc Cita; Košnik Mitja
    Angiotensin-converting enzyme inhibitors as a cause of isolated angioedema in a Slovenian population
    2016
  14. Hočevar Keli; Peterlin Ana; Mitrović-Jovanović Ana; Ristanović Momčilo; Tul Nataša; Peterlin Borut
    Association between angiotensin-converting enzyme gene insertion/deletion polymorphism and susceptibility to preterm birth
    2018
  15. Pitt Bertram; Bushinsky David A.; Kitzman Delane W.; Ruschitzka Frank; Metra Marco; Filippatos Gerasimos; Rossignol Patrick; Du Mond Charles; Garza Dahlia; Berman Lance; Lainščak Mitja
    Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney disease
    2018
  16. Canepa Marco; Straburzynska-Migaj Ewa; Drozdz Jaroslaw; Garcia Pinilla Jose Manue; Nyolczas Noemi; Temporelli Pier Luigi; Mebazaa Alexandre; Lainščak Mitja; Laroche Cécile; Maggioni Aldo P.
    Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry
    2018
  17. Štuhec Matej; Keuschler Jan; Serra-Mestres Jordi; Isetta M.
    Effects of different antihypertensive medication groups on cognitive function in older patients
    2017
  18. Kotseva Kornelia; Wood David; De Bacquer Dirk; De Backer Guy; Rydén Lars; Jennings Catriona S.; Gyberg Viveca; Amouyel Philippe; Bruthans Jan; Fras Zlatko
    EUROASPIRE IV
    2016
  19. Makuc Jana; Šeruga Maja; Završnik Matej; Cilenšek Ines; Petrovič Danijel
    Angiotensinogen (AGT) gene missense polymorphisms (rs699 and rs4762) and diabetic nephropathy in Caucasians with type 2 diabetes mellitus
    2017
  20. Šeruga Maja; Makuc Jana; Završnik Matej; Cilenšek Ines; Ekart Robert; Petrovič Danijel
    Polymorphism of angiotensin-converting enzyme (rs4340) and diabetic nephropathy in Caucasians with type 2 diabetes mellitus
    2016
  21. Ristić Smiljana; Starčević-Čizmarević Nada; Lavtar Polona; Lovrečić Luca; Perković Olivio; Sepčić Juraj; Šega Saša; Kapović Miljenko; Peterlin Borut
    Angiotensin-converting enzyme insertion/deletion gene polymorphism and interferon-[beta] treatment response in multiple sclerosis patients
    2017
  22. Cafuta Maček Eva; Košnik Mitja; Korošec Peter
    Pogostost, patogeneza in dejavniki tveganja za nastanek angiodema ob prejemanju zaviralcev angiotenzinove konvertaze
    2015
  23. Merlo Sebastjan; Novák J; Tkáčová N; Nikolajević-Starčević Jovana; Šantl-Letonja Marija; Makuc Jana; Cokan Vujkovac Andreja; Letonja Jaušovec Lidija; Bregar Dejan; Zorc Marjeta; Rojko Maksimiljana; Mankoč Ramuš Sara; Kruzliak Peter; Petrovič Danijel
    Association of the ACE rs4646994 and rs4341 polymorphisms with the progression of carotid atherosclerosis in Slovenian patients with type 2 diabetes mellitus
    2015
  24. Rupnik Erik; Kariž Stojan; Iglič Črtomir; Zidarn Mihaela; Košnik Mitja
    Življenje ogrožajoči angioedem po zaviralcu angiotenzinove konvertaze - prikaz dveh primerov
    [Life-threatening angioedema induced by angiotensin-converting enzyme inhibitor - two case reports]
    2015
  25. Ademosun Ayokunle O.; Oboh Ganiyu; Passamonti Sabina; Tramer Federica; Žiberna Lovro; Boligon Aline Augusti; Athayde Margareth Linde
    Phenolics from grapefruit peels inhibit HMG-CoA reductase and angiotensin-I converting enzyme and show antioxidative properties in endothelial EA.Hy 926 cells
    2015
  26. Pal Marjetka; Ferk Polonca
    Interakcije zdravil z zaviralci angiotenzinske konvertaze
    [Drug interactions with angiotensin-converting enzyme inhibitors]
    2012
  27. Janić Miodrag; Lunder Mojca; Šabovič Mišo
    Arterial stiffness and cardiovascular therapy
    2014
  28. Trošt Rupnik Alijana; Pajek Jernej; Guček Andrej; Osredkar Joško; Kovač Damjan; Bren Andrej; Klančič Dimitrij; Saksida Silvana; Rus Igor; Globokar Mateja; Drozg Andrej; Lešnik Marjeta; Plešivčnik Zala; Ekart Robert; Kralj Lopert Simona; Lindič Jelka
    Influence of renin-angiotensin-aldosterone system-blocking drugs on peritoneal membrane in peritoneal dialysis patients
    2013
  29. Klupka-Sarić Inge; Peterlin Borut; Lovrečić Luca; Sinanović Osman; Vidović Mirjana; Sehanović Aida; Starčević-Čizmarević Nada; Sepčić Juraj; Kapović Miljenko; Ristić Smiljana
    Angiotensin-Converting Enzyme Gene Polymorphism in Patients with Multiple Sclerosis from Bosnia and Herzegovina
    2011
  30. Tomasik Tomasz; Windak Adam; Jozwiak Jacek; Oleszczyk Marek; Seifert Bohumil; Kersnik Janko; Kryj-Radziszewska Elzbieta
    Treatment of hypertension in central and eastern European countries: self-reported practice of primary care physicians
    2012
  31. Trobec Katja; von Haehling Stephan; Anker Stefan D; Lainščak Mitja
    Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexia
    2011
  32. Springer Jochen; Lainščak Mitja; Salobir Barbara; Lang Irene M
    Treatment of pulmonary hypertension: bench to bedside
    2011
  33. Bevc Sebastjan
    Aldosteron, zaviralci aldosteronskih receptorjev in kronična ledvična bolezen
    [Aldosterone, aldosterone receptor blockers and chronic kidney disease]
    2011
  34. Camm AJ; Kirchhof P; Lip GY; Zupan I
    Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC)
    2010
  35. Štimac Danijela; Polić-Vižintin Marina; Škes Marija; Cattunar Albert; Cerović Robert; Stojanović Dražen
    Utilization of cardiovascular drugs in Zagreb 2001-2005
    2010
  36. Vrtovec Bojan; Poglajen Gregor
    Sodobni načini zdravljenja srčnega popuščanja
    [Modern treatment methods for heart failure]
    2011
  37. Terčelj Marjeta; Salobir Barbara; Zupančič Mirjana; Rylander Ragnar
    Antifungal medication is efficient in the treatment of sarcoidosis
    2011
  38. Bajuk-Studen Katica; Šebeštjen Miran; Pfeifer Marija; Preželj Janez
    Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
    2011
  39. Sinkovič Andreja
    Age-related short-term effect of ramipril on N-terminal pro-brain natriuretic peptide and markers of hemostasis in patients after acute myocardial infarction
    2010
  40. Zupan Igor; Lipar Luka
    Doseganje ciljne srčne frekvence, antiishemična učinkovitost in prenašanje zdravila ivabradin pri bolnikih s stabilno angino pektoris (raziskava OPTIMAL 60)
    [Target heart rate achievement, antiishemic drug efficacy and tolerability of ivabradin in patients with stable angina pectoris (OPTIMAL 60 study)]
    2010
  41. Zajc Milita; Zupan Anton; Bunc Matjaž
    Prizadetost srca pri mišičnih in živčno-mišičnih obolenjih
    [Cardiac involvement in muscle and neuromuscular disorders]
    2010
  42. Sinkovič Andreja
    Bolnik z akutnim miokardnim infarktom - ukrepi ob akutnem dogodku in ukrepanje v bolnišnici
    2010
  43. Šušteršič Miha; Bunc Matjaž
    Nova spoznanja o reninsko-angiotenzinskemu sistemu s poudarkom na (pro)reninu in (pro)reninskem receptorju ter možnostih njune zavore
    [New knowledge of renin-anginotensin-aldosterone system with emphasis on (pro)renin, (pro)renin receptor and possibilities of their blockade]
    2009
  44. Marinšek Martin; Sinkovič Andreja
    A randomized trial comparing the effect of ramipril and losartan in survivors of ST-elevation myocardial infarction
    2009
  45. Lainščak Mitja; Coletta Alison P; Sherwi Nasser; Cleland John G
    Clinical trials update from the Heart failure society of America meeting 2009: FAST, IMPROVE-HF, COACH galectin-3 substudy, HF-ACTION nuclear substudy, DAD-HF, and MARVEL-1
    2009
  46. Terčelj Marjeta; Salobir Barbara; Simčič Saša; Wraber Branka; Zupančič Mirjana; Rylander Ragnar
    Chitotriosidase activity in sarcoidosis and some other pulmonary diseases
    2009
  47. Magdič Jožef
    Pleotropni učinki zdravil v preventivi možganskožilnih bolezni
    [Pleiotrophic effects of drugs used for stroke prevention]
    2009
  48. Bombek Mirko
    Ali z izbiro antihipertenzivnega zdravljenja lahko upočasnimo razvoj srčnožilnih bolezni in njihovih posledic?
    [Are we able to slow down the progress of cardiovascular diseases and their fatal events with proper choice of antihipertensive treatment?]
    2009
  49. Bajuk-Studen Katica; Preželj Janez; Kocjan Tomaž; Pfeifer Marija
    Mehanizmi srčno-žilne orgroženosti žensk s sindormom policističnih ovarijev
    [Mechanisms of cardiovascular disease risks in women with polycystic ovary syndrome]
    2009
  50. Šušteršič Miha; Bunc Matjaž
    Nova spoznanja o reninsko-angiotenzisko-aldosteronskem sistemu in nove strategije njegove zavore
    [New knowledge of renin-angiotensin-aldosterone system and new strategies of its blockade]
    2008
  51. von Haehling Stephan; Lainščak Mitja; Springer Jochen; Anker Stefan D
    Cardiac cachexia: a systematic overview
    2008
  52. Poredoš P; Jeiovnik MK
    Does the preventive effect of different drugs depend on location of the atherosclerotic process?
    2008
  53. Dzurenkova D; Hruškovičova H; Kovacs L
    Association between athletic performance and insertion/deletion polymorphism of the gene for angiotensin-converting enzyme
    2002
  54. Petrovič Daniel
    Optimizing cardiac and vascular protection in hypertensive patients with type 2 diabetes
    2008
  55. Salobir B; Medica I; Terčelj M; Kastrin A; Šabovič M; Peterlin B
    Association of angiotensin-converting enzyme/DD genotype with sarcoidosis susceptibility in Slovenian patients
    2007
  56. Osredkar Joško
    Priporočila za uporabo biokemijskih označevalcev pri srčnem popuščanju
    [Recommendations on the use of biochemical markers in heart failure]
    2007
  57. Lainščak Mitja; Cleland John GF; Lenzen Mattie J; Keber Irena; Goode Kevin; Follath Ferenc; Komajda Michel; Swedberg Karl
    Nonpharmacologic measures and drug compliance in patients with heart failure: data from the EuroHeart failure survey
    2007
  58. Virant Mojca
    Vpliv izbranih zaviralcev angiotenzinskega sistema na poškodbe hipoksije-reoksigenacije izolirane prašičje koronarne arterije
    2006
  59. Vrtovec Bojan
    Zdravljenje z zdravili po prebolelem miokardnem infarktu
    2007
  60. Šabovič Mišo
    Pomen zaviralcev angiotenzinske konvertaze pri zdravljenju ishemične bolezni srca
    [The role of ACE inhibitors in the treatment of coronary artery disease]
    2007
  61. Blinc A; Poredoš P
    Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease
    2007
  62. Glavnik N; Petrovič D
    M235T polymorphism of the angiotensinogen gene and insertion/deletion polymorphism of the angiotensin-1 converting enzyme gene in essential arterial hypertension in caucasians
    2007
  63. Lainščak Mitja; Cleland John GF; Lenzen Mattie J; Follath Ferenc; Komajda Michel; Swedberg Karl
    International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart failure survey
    2007
  64. Kolšek Borut
    Neželeni učinki zdravil, ki delujejo na os renin-angiotenzin-aldosteron
    2006
  65. Lovrečić L; Ristić S; Starcević-Čizmarević N; Jazbec ; Sepcić J; Kapović M; Peterlin B
    Angiotensin-converting enzyme I/D gene polymorphism and risk of multiple sclerosis
    2006
  66. Keber Irena
    Pomen antagonistov aldosterona pri zdravljenju kroničnega srčnega popuščanja
    2006
  67. Medica Igor; Kastrin Andrej; Peterlin Borut
    Genetic polymorphisms in vasoactive genes and preeclampsia: a meta-analysis
    2007
  68. Gužič-Salobir Barbara
    Pomen renin-angiotenzinskega sistema pri bolnikih s srčnim popuščanjem
    [The meaning of renin-angiotensin system with patients who have heart failure]
    2006
  69. Keber Irena
    Posodobljene evropske smernice za obravnavo kroničnega srčnega popuščanja - kaj je novega pri farmakološkem zdravljenju
    [The updated European guidelines for the treatment of chronical heart failure - what is new in pharmacological treatment]
    2006
  70. Jug Borut; Šebeštjen Miran; Šabovič Mišo; Keber Irena
    Clopidogrel is associated with a lesser increase in NT-proBNP when compared to aspirin in patients with ischemic heart failure
    2006
  71. Eržen Barbara; Gradišek Primož; Poredoš Pavel; Šabovič Mišo
    Treatment of essential arterial hypertension with enalapril does not result in normalization of endothelial dysfunction of the conduit arteries
    2006
  72. Lipnik-Štangelj Metoda
    Farmakološko zdravljenje arterijske hipertenzije
    2006
  73. Ferjan Mateja; Goličnik Alenka
    Vpliv aktivacije vnetnega odgovora na anemijo pri bolnikih s srčnim popuščanjem
    2005
  74. Klemenc Matjaž
    Zdravljenje bolnika s stabilno angino pektoris z inhibitorji angiotenzinske konvertaze in zaviralci receptorjev za angiotenzin II
    2006
  75. Zorc-Pleskovič Ruda; Teran Nataša; Pleskovič Aleš; Milutinović Aleksandra
    Deletion/deletion genotype of angiotensin-I converting enzyme gene is not associated with coronary artery disease in Caucasians with type 2 diabetes
    2005
  76. Poredoš P
    Prevention of different atherosclerotic diseases: does the effect of preventive measures depend on location of the atherosclerotic process?
    2006
  77. Terzić Rifet; Letonja Mitja; Terzić Ibrahim; Šehić Amela; Merić Muharem; Teran Nataša
    Insertion/deletion polymorphism of angiotensin-converting enzyme gene - risk factor for coronary artery disease in the Tuzla region population (Bosnia and Herzegovina)
    [Insercijski/delecijski polimorfizam u genu angiotenzin konvertirajučeg enzima (ACE) - čimbenik rizika bolesti koronarnih arterija u stanovništvu Tuzlanske regije (Bosna i Herzegovina)]
    2003
  78. Černe Andreja; Kranjec Igor; Peterlin Borut
    Angiotensin-converting enzyme gene polymorphism and acute coronary syndrome
    [Polimorfizmi gena za encim angiotenzinsko konvertazo pri bolnikih z akutnim koronarnim sindromom]
    2005
  79. Bren Andrej; Kandus Aljoša
    Our experience with epoetins in treating renal anemia
    2005
  80. Pajek Jernej; Bučar-Pajek Maja; Grego Katarina; Guček Andrej; Bevc Sebastjan; Ekart Robert; Vujkovac Bojan; Golob-Kosmina Polona; Kandus Aljoša; Bren Andrej F
    Epoetin responsiveness in peritoneal dialysis patients: a multi-center Slovenian study
    2005
  81. Šebeštjen Miran
    Zdravljenje bolnika s srčnim popuščanjem
    2004
  82. Osolnik Katarina
    Interakcije zdravil pri bolnikih z alergijskimi boleznimi in astmo
    2005
  83. Eržen Barbara; Gradišek Primož
    Spremembe žilne stene in sestave krvi pri arterijski hipertenziji
    1995
  84. Vujkovac Bojan; Cokan Andreja; Verovnik Franc; Šabovič Mišo; Benko Davorin
    Effect of angiotensin-converting enzyme inhibitors on proteinuria in patients with fabry disease treated with enzyme replacement therapy
    2005
  85. Kranjec Igor
    Dolgoročna uporaba zaviralcev angiotenzinske konvertaze (ACE) pri bolnikih s koronarno aterosklerozo
    2005
  86. Fras Zlatko; Jug Borut
    Kakovost zgodnje sekundarnopreventivne oskrbe bolnikov po srčnem infarktu v nekaterih slovenskih bolnišnicah
    [Quality of early secondary prevention care after acute myocardial infarction in some of the Slovene hospitals]
    2005
  87. Možina Martin; Jamšek Marija; Šarc Lucija; Grenc Damjan; Brvar Miran
    Zastrupitve
    2005
  88. Cerk Kristina
    Hiperkaliemija pri zdravljenju srčnega popuščanja
    2004
  89. Petrovič Daniel; Peterlin Borut
    Genetic markers of restenosis after coronary angioplasty and after stent implantation
    2005
  90. Marčun-Varda N; Peterlin B; Umek-Bradač S; Gregorič A
    Carotid artery intima-media thickness and angiotensin-converting enzyme gene polymorphism in the offspring of parents with premature stroke
    2005
  91. Vašku V; Vašku JA; Pavkova-Goldbergova M; Vašku A
    Association of variants in angiotensin-converting enzyme and endothelin-1 genes with phototherapy in cutaneous T-cell lymphoma
    2004
  92. Dobovišek Jurij
    Zdravljenje hipertenzijske hipertrofije levega prekata
    2004
  93. Kolšek Borut; Klemenc Matjaž
    Nadzor hipertenzije pri srčni odpovedi
    2004
  94. Kolšek Borut
    Nadzor hipertenzije pri ishemični bolezni srca
    2004
  95. Žemva Aleš
    Pregled antihipertenzijskih zdravil
    2004
  96. Dobovišek Jurij
    Terapevtski pristop k hipertenziji
    2004
  97. Lainščak Mitja
    Implementation of guidelines for management of heart failure in heart failure clinic: effects beyond pharmacological treatment
    2004
  98. Accetto Rok
    Izbira antihipertenzijskega zdravila
    2004
  99. Kržišnik-Zorman Simona
    Koronarna bolezen pri starostnikih - zdravljenje bolnikov z akutnim miokardnim infarktom
    [Coronary disease in elderly patients - management of patients with acute myocardial infarction]
    2004
  100. Žemva Aleš
    Klinične in farmakološke značilnosti zdravil za zniževanje krvnega tlaka
    2004

1 101 201  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics